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1. Introduction 
Recent studies [ 1,2] demonstrated that Distamy- 
tin A, a basic oligopeptide antibiotic produced by 
Streptomyces distallicus, inhibits the synthesis of 
DNA by Rous Sarcoma virus (RSV) reverse transcriptase 
[3-51. It was found that Distamycin A and two of 
its derivatives, compounds II and XIII (fig. 1) have 
a partial inhibitory effect on the reverse transcriptase, 
even at the high concentrations tested (100 pg/ml). 
The inhibitory effect of the antibiotics can be ex- 
plained by the ability of Distamycin A molecules to 
interact with double- and single-stranded DNA mole- 
cules [6, 71. It was also reported that Distamycin A 
binds to polyguanylic acid [8] and to RNA [9]. In 
the present study we compared the effect of the 
antibiotic congocidine (fig. l), which resembles 
Distamycin A, on the activity of RSV reverse tran; 
scriptase and the effect of Distamycin A on the 
nature of the DNA molecules synthesized in vitro 
by RSV enzyme. 
2. Materials and methods 
RSV, B7, strain, was harvested from the culture 
medium of transformed chick fibroblasts. The virus 
was concentrated loo-fold, purified by centrifugation 
in sucrose gradients (15-65%, w/v), treated with 
Nonidet P-40 and the enzymatic activity was 
assayed according to the method of Temin and Mizu- 
tani [3]. The assay system consisted of dATP, dGTP 
(Schwarz, Orangeburg, N.Y., USA) and dCTP (Sigma, 
St. Louis, Missouri, USA), 0.125 pmoles each in 
0.02 M Tris-HCl buffer at pH 8.1, containing 0.33 mM 
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EDTA and 1.7 mM dithiothreitol; 1.5 pmoles of 
MgClz and 2.5 pmoles of KCl; 2.5 pg phosphoenol- 
pyruvate (Sigma) and 10 l.(g pyruvate kinase (Sigma); 
2.5 @i of 3H-TTP (Radiochemical Centre, Amersham, 
England; specific activity 10.35 Ci/mmole) and 0.025 
ml of the virus preparation which contained 15-20 
pg protein. The polymerase assays were carried out 
in the presence of various concentrations of the anti- 
biotics. Distamycin A was obtained from Farmitalia, 
Italy and congocidine from Rhbne-Poulenc Labora- 
tories, France. 
The nature of the DNA species synthesized by RSV 
reverse transcriptase in the absence or in the pres- 
ence of Distamycin A and congocidine (100 pg/ml 
reaction mixture) was studied by elution from hydroxyl- 
apatite [ 10, 1 l] columns with a linear sodium phos- 
phate gradient [lo] . Hydroxyapatite was obtained 
from Bio-Rad Lab, Richmond, Calif. The reaction 
mixtures were dissolved with sodium dodecyl sulfate 
(l%, w/w, final concentration), loaded on the hydroxyl- 
apatite, eluted with a sodium phosphate gradient 
ranging from 0.05-0.4 M, collected into about 40 
fractions and the TCA precipitable radioactivity was 
collected on filters and counted in a liquid scintilla- 
tion counter. Herpes simplex virus (HSV) purified 
DNA, labeled with 14C-thymidine was used as a 
marker (Gordin, Olshevsky and Becker, to be published). 
The HSV-DNA eluted from the hydroxylapatite 
column prior to HeLa cell DNA. 
3. Results 
The results presented in fig. 2 demonstrate that the 
antibiotics Distamycin A and congocidine affected the 
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Fig. 2. The effect of Distamycin A and congocidine on DNA 
synthesis by RSV reverse transcriptase. The enzymatic reac- 
tion mixtures were treated with various concentrations of the 
antibiotics and incubated for 60 min at 37”. The radioactivity 
incorporated into the precipitable DNA was determined. The 
background of the reaction mixture, without the addition of 
the enzyme, is about SO-90 cpm. 
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Fig. 1. The structure of Distamycin A and related compounds. 
synthesis of DNA by RSV reverse transcriptase; the 
inhibitory effect of congocidine was less marked than 
that of Dismmycin A. However, the extent of the in- 
hibitory effect varied somewhat in the various experi- 
ments performed. In addition, it can be seen (fig. 2) 
that even at a concentration of 100 pg/ml Distamycin 
A only had a partial inhibitory effect on DNA syn- 
thesis by the RSV reverse transcriptase. 
The effect of Distamycin A (at a cont. of 100 pg/ 
ml) on the kinetics of 3H-TMP incorporation by 
the reverse transcriptase is shown in fig. 3. It was 
found that Distamycin A markedly affected, but did 
not prevent the synthesis of DNA by the RSV en- 
zyme when added to the enzymatic reaction prior 
to the initiation of DNA synthesis. The 3H-TMP in- 
corporation in the presence of the antibiotic contin- 
ued for 30 min and then stopped. The untreated en- 
zyme continuously synthesized DNA for 60 min. 
The dilution of the enzyme with the buffer (fig. 3A) 
resulted in a reduction in the extent of 3H-TMP in- 
corporation. Addition of Distamycin A to the enzyme 
at 2 concentrations, 25 pg/ml and 100 &ml, 5 min 
after the initiation of DNA synthesis, also markedly 
affected the synthesis of DNA but 3H-TMP incorpo- 
ration continued for an additional period of 10 to 20 
min. In this respect, the effect of Distamycin A on 
the RSV DNA polymerase differed from that of 
rifampicin [l] , which completely inhibited DNA syn- 
thesis, but it resembled the inhibitory effect exerted 
by actinomycin D [2, 111. 
The nature of the DNA products synthesized by 
the RSV reverse transcriptase in the presence of 
Distamycin A was further investigated (fig. 4). It was 
found that the viral DNA, which was synthesized by 
the untreated RSV reverse transcriptase in vitro 
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Fig. 3. Effect of Distamycin A on the kinetics of 3H-TMP 
incorporation into DNA molecules by RSV DNA polymer- 
ases. Four polymerase assays (see fig. l), each containing 
250 ~1 were prepared. Distamycin A was dissolved in Tris- 
HCl EDTA buffer pH 8.1 and added to the reaction mix- 
tures. One reaction mixture (A) served as a control, to (B) 
Distamycin A (final concentration 100 pg/ml) was added in 
the cold and the four tubes were incubated at 37”. At 5 
min after initiation of DNA synthesis Distamycin A (25 
pg/ml and 100 rg/ml) was added to tube (C) and (D) , re- 
spectively. The same amount of buffer was added also to 
(A). At different time intervals, duplicate samples of 25 id 
were removed from each reaction mixture and the TCA 
precipitable radioactivity was determined. 
eluted as three species from a hydroxylapatite column. 
The first species to be eluted from the column contain- 
ed single stranded DNA molecules (ssDNA). The second 
species contained the RNA:DNA hybrid molecules 
(hyDNA) and finally the double stranded DNA mole- 
cules (dsDNA) eluted just prior to the HSV-DNA 
marker (fig. 4A). Treatment of the DNA products 
with alkali (0.2 N, 18 hr at 37”) resulted in the dena- 
turation of the double stranded DNA molecules and 
the appearance of ssDNA molecules which were 
eluted with the first DNA species (fig. 4A). Anal- 
ysis of the DNA species synthesized by the reverse 
transcriptase in the presence of 100 pg/ml (2 X 10m4 
M) Distamycin A (fig. 4B) demonstrated that ssDNA 
and hyDNA, but not dsDNA species, were synthe- 
sized. The antibiotic did not stimulate the synthesis 
of ssDNA and hyDNA. These results indicated that 
Distamycin A inhibited the enzymatic step necessary 
to form dsDNA from ssDNA and did not affect the 
synthesis of hyDNA and ssDNA. Analysis of the 
viral DNA species synthesized by RSV reverse tran- 
scriptase in the presence of congocidine revealed 
(fig. 4C) that although less 3H-TMP was incorporated 
by the treated viral enzyme, all three DNA species 
were synthesized. 
4. Discussion 
Distamycin A was reported to inhibit the replica- 
tion of DNA viruses [ 12, 131 and phages [ 141. Stu- 
dies on the physical properties of this antibiotic [6] 
demonstrated that the melting profile of native calf 
thymus DNA shifts towards higher temperatures 
when increasing antibiotic concentrations are added 
to the DNA solution. It was therefore concluded [6] 
that Distamycin A strongly binds to dsDNA and 
ssDNA, while less interactions have been demonstrated 
with ssRNA. Due to its ability to bind to DNA, Dis- 
tamycin A also inhibits the template activity of both 
native and denatured DNA [6, 151. These findings 
might also explain the effect of Distamycin A on 
DNA synthesis by RSV reverse transcriptase. We 
assume that Distamycin A has a low affinity to the 
RSV viral RNA and therefore does not inhibit the 
synthesis of hyDNA and ssDNA molecules. Due to 
its interaction with the viral ssDNA or hyDNA mole- 
cules, Distamycin A inhibits the synthesis of viral 
dsDNA. 
The observation that congocidine had a lesser in- 
hibitory effect on RSV reverse transcriptase than 
Distamycin A might indicate that the structure of 
the antibiotic molecule might influence its antiviral 
activity. The results presented here on the effect of 
congocidine can be compared to those reported on 
the effect of two derivatives of Distamycin A (com- 
pounds II and XIII, fig. 1) on RSV reverse transcrip- 
tase previously reported [ 11. It can be concluded 
that a) an increase in the number of pyrrole rings in- 
creased the antiviral activity of the antibiotic. The 
most active compound XIII has 5 pyrrole rings; 
Distamycin A has 3 pyrrole rings; congocidine 2 
pyrroie rings. b) The nature of the variable sidechain 
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Fig. 4. Analysis of the DNA synthesized by RSV reverse transcriptase by elution from hydroxylapatite column. (A) The DNA 
molecules synthesized in vitro by B77 DNA polymerase. The dotted line represents a parallel experiment in which the 
reaction mixture was treated with 0.2 M NaOH for 18 hr at 37” and neutralized with 0.2 M HCl before loading on the column. (B) 
DNA molecules synthesized in the presence of 100 pg/ml Distamycin A and (C) DNA molecules synthesized in the presence of 100 
rg/ml congocidine. Native Herpes Simplex Virus (HEW) DNA, labeled with 14C-thymidine was used as a marker in each column. B77 
virus reaction mixture (0.5 ml each; see text) was incubated for 60 mm at 37” either without or with the antibiotics. Before analysis 
on the hydroxylapatite columns, sodium dodecyl sulfate (SDS) was added to each sample at a final concentration of 1% (w/v). Each 
column was filled with 1 g of hydroxylapatite (Bio-Rad Lab., Richmond, Calif.) and carefully washed with 0.05 M sodium phos- 
phate. The columns were loaded with the reaction products together with HSV-DNA as a marker. The columns were washed with a 
solution of 0.05 M sodium phosphate buffer, pH 6.8, until equilibrium was reached. Macromolecules were eluted from the columns 
by a linear gradient of sodium phosphate, ranging from 0.05 M to 0.4 M. The effluent, total volume of 100 ml, was collected in 40 
tubes, every 5th sample was measured for the refraction index by the Bausch and Lomb refractometer. The TCA precipitable radio- 
activity in each fraction was collected on filters and determined in a Packard liquid scintillation counter. (e-04) B77 virus product 
DNA; (0-o-o) HSV-DNA-14C; ( ---;) phosphate concentration; (C -a- -0) alkali treated viral DNA. 
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has an additional importance in the antiviral activity 
as it was found that Distamycin A is more effective 
than its derivative compound II [ 1, 21. This con- 
clusion is in agreement with the findings of Chandra 
et al. [8] that the antiviral activity of Distamycins 
and their action on the template activity of DNA 
are dependent on the number of pyrrole rings and 
that the sidechain l-methyl-pyrrole-2carboxamide 
(present in Distamycin A and compound XIII) might 
be involved in the binding of the antibiotic to DNA 
PI . 
The results of the present study indicate that 
Distamycin A, a natural fermentation product, whose 
structure was elucidated by total synthesis [ 161, 
might represent a group of antibiotics with activities 
against Oncorna virus reverse transcriptase. The re- 
quirement for pyrrole groups and sidechains might 
provide an approach to the synthesis of new anti- 
viral substances with specific activities against viruses 
which have DNA genomes or DNA molecules as a 
primary transcription product. 
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